Moleculin Biotech Inc (MBRX)
5.08
+0.05
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
5.08
0.00 (0.00%)
After-Hours: 16:26
Moleculin Biotech Cash and Short Term Investments (Quarterly): 16.82M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 16.82M |
| December 31, 2023 | 23.55M |
| September 30, 2023 | 24.58M |
| June 30, 2023 | 32.17M |
| March 31, 2023 | 37.26M |
| December 31, 2022 | 43.14M |
| September 30, 2022 | 50.39M |
| June 30, 2022 | 58.00M |
| March 31, 2022 | 66.10M |
| December 31, 2021 | 70.90M |
| September 30, 2021 | 75.18M |
| June 30, 2021 | 79.51M |
| March 31, 2021 | 86.29M |
| December 31, 2020 | 15.17M |
| September 30, 2020 | 12.80M |
| June 30, 2020 | 16.73M |
| March 31, 2020 | 11.65M |
| Date | Value |
|---|---|
| December 31, 2019 | 10.74M |
| September 30, 2019 | 15.41M |
| June 30, 2019 | 18.70M |
| March 31, 2019 | 8.782M |
| December 31, 2018 | 7.134M |
| September 30, 2018 | 8.60M |
| June 30, 2018 | 11.72M |
| March 31, 2018 | 13.11M |
| December 31, 2017 | 7.714M |
| September 30, 2017 | 8.736M |
| June 30, 2017 | 9.272M |
| March 31, 2017 | 8.881M |
| December 31, 2016 | 5.007M |
| September 30, 2016 | 6.184M |
| June 30, 2016 | 7.245M |
| March 31, 2016 | 0.2597M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
10.74M
Minimum
Dec 2019
86.29M
Maximum
Mar 2021
38.26M
Average
28.38M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Merck & Co Inc | 5.619B |
| Lixte Biotechnology Holdings Inc | 3.414M |
| Moderna Inc | 8.523B |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 9.485M |